ABCL
Abcellera Biologics Inc
13.70$
-1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +31.5% | +1,907.9% | -95.0% | +4,080.5% | -92.2% | -24.2% | +160.6% | |
| – | +74.3% | +168.4% | +67.7% | +46.0% | -53.5% | +214.0% | -70.3% | |
| – | +31.5% | +1,674.1% | -94.4% | +3,508.4% | -90.9% | -24.2% | +60.6% | |
| – | +74.3% | +190.6% | +111.1% | +73.8% | +62.8% | -4.8% | +11.7% | |
| – | +27.8% | +333.2% | -76.9% | +1,918.5% | +9.9% | +19.2% | +14.5% | |
| – | +64.1% | +217.8% | -72.1% | +1,351.0% | +35.9% | +24.8% | -23.3% | |
| – | – | – | -102.6% | – | -209.6% | – | – | |
| – | -1.4% | +3,015.3% | -96.8% | +1,833.6% | – | – | – | |
| – | -815.5% | – | -101.4% | – | -172.8% | – | – | |
| – | -83.6% | +18,502.2% | +68.8% | +22.7% | -134.3% | – | – | |
| – | -815.5% | – | -101.9% | – | -192.4% | – | – | |
| – | -110.8% | – | -100.1% | – | -173.9% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.